Location of Repository

Medical technology as a key driver of rising health expenditures: disentangling the relationship

By Corinna Sorenson, Michael Drummond and Beena Bhuiyan Kahn


Health care spending has risen steadily in most countries, becoming a concern for decision-makers worldwide. Commentators often point to new medical technology as the key driver for burgeoning expenditures. This paper critically appraises this conjecture, based on an analysis of the existing literature, with the aim of offering a more detailed and considered analysis of this relationship. Several databases were searched to identify relevant literature. Various categories of studies (eg, multivariate and cost-effectiveness analyses) were included to cover different perspectives, methodological approaches, and issues regarding the link between medical technology and costs. Selected articles were reviewed and relevant information was extracted into a standardized template and analyzed for key cross-cutting themes, ie, impact of technology on costs, factors influencing this relationship, and methodological challenges in measuring such linkages. A total of 86 studies were reviewed. The analysis suggests that the relationship between medical technology and spending is complex and often conflicting. Findings were frequently contingent on varying factors, such as the availability of other interventions, patient population, and the methodological approach employed. Moreover, the impact of technology on costs differed across technologies, in that some (eg, cancer drugs, invasive medical devices) had significant financial implications, while others were cost-neutral or cost-saving. In light of these issues, we argue that decision-makers and other commentators should extend their focus beyond costs solely to include consideration of whether medical technology results in better value in health care and broader socioeconomic benefits

Topics: HJ Public Finance, RA Public aspects of medicine
Publisher: Dovepress
Year: 2013
DOI identifier: 10.2147/CEOR.S39634
OAI identifier: oai:eprints.lse.ac.uk:48043
Provided by: LSE Research Online
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://eprints.lse.ac.uk/48043... (external link)
  • http://www.dovepress.com/clini... (external link)
  • http://eprints.lse.ac.uk/48043... (external link)
  • Suggested articles



    1. (1995). A historical analysis of medical spending growth, 1960–1993. Health Affairs. doi
    2. Applying health economics for policy decision making: how much do devices differ from drugs? doi
    3. (2009). Available from: http:// www.cdc.gov/nchs/data/hus/hus09.pdf. Accessed
    4. (2013). Available from: http://heartland.org/sites/all/modules/custom/ heartland_migration/files/pdfs/14621.pdf. Accessed
    5. (2005). Cardiac resynchronization therapy (CRT) in heart failure: a model to assess the economic value of this new medical technology. Value Health. doi
    6. (1985). Changes in the cost of treatment of selected illnesses, 1971–1981. Med Care.
    7. (1992). Contributions of case mix and intensity change to hospital cost increases. Health Care Financ Rev.
    8. Cost and effectiveness of hip protectors among the elderly.
    9. Cost-effectiveness of cemented versus cementless total hip anthroplasty. A Markov decision analysis based on implant cost. doi
    10. Cost-effectiveness of drug-eluting stents in patients at high or low risk of major cardiac events in the Basel Stent KostenEff Ektivitäts Trial (BASKET): an 18-month analysis. doi
    11. Cost-effectiveness of hip protectors in the prevention of osteoporosis related hip fractures in elderly nursing home residents.
    12. Costeffectiveness of drug eluting coronary artery stenting in a UK setting: cost-utility study. doi
    13. Costs and outcomes of total hip and knee joint replacement for rheumatoid arthritis. Clin Rheumatol. doi
    14. Diffusion of innovations in health care: does the structural context determine its direction? doi
    15. Does health care spending improve health outcomes? Evidence from English programme budgeting data. doi
    16. (1996). Economics, values, and health care reform. Am Econ Rev.
    17. (2011). Estimates of Medical Device Spending in the United States.
    18. (1990). Estimating costs in the economic evaluation of medical technologies. doi
    19. Estimating the impact of a diffuse technology on the running costs of a hospital. doi
    20. (1999). Health care for the elderly: how much? Who will pay for it? Health Aff (Millwood).
    21. (1995). Health Costs, and the NIH, Harvard University and the National Bureau of Economic Research. Paper prepared for the National Institutes of Health Economics Roundtable on Biomedical Research;
    22. (2003). Hospital cost drivers: an evaluation of 1998–2001 state-level data. Am J Manag Care.
    23. In-hospital costs of self-expanding nitinol stent implantation vs. balloon angioplasty in the femoropopliteal artery (The VascuCoil Trial). doi
    24. Is managed care restraining the adoption of technology by hospitals? doi
    25. (2001). Is technological change in medicine worth it? Health Aff (Millwood). doi
    26. (1997). Managed care and medical technology: implications for cost growth. Health Aff (Millwood). doi
    27. Managed care and technology adoption in health care: evidence from magnetic resonance imaging. doi
    28. (1992). Medical care costs: How much welfare loss? J Econ Perspect. doi
    29. (1994). Medical innovation duels cost containment. Health Aff (Millwood). doi
    30. Medical technology procurement in Europe: a cross-country comparison of current practice and policy. Health Policy. doi
    31. (2008). Office. Technological Change and The Growth of Health Care Spending. Congressional Budget Office: Washington, DC: Congressional Budget Office; doi
    32. One-year cost-effectiveness of sirolimus eluting stents compared with bare metal stents in the treatment of single native de novo coronary lesions: an analysis from the Ravel trial. doi
    33. (2010). Organisation for Economic Co-operation and Development. OECD Health at a Glance: Europe 2010. Paris, France: Organisation for Economic Co-operation and Development; doi
    34. (2011). Organisation for Economic Co-operation and Development. OECD Health Data 2011. Paris, France: Organisation for Economic Co-operation and Development; doi
    35. (2006). Organisation for Economic Co-operation and Development. Projecting OECD Health and Long Term Care Expenditures: What are the Main Drivers? Organisation for Economic Co-operation and Development Economic Department Working Paper, No 477; doi
    36. (2001). Physicians’ views of the relative importance of thirty medical innovations. Health Aff (Millwood). doi
    37. (2009). Review and Dissemination. Abstractors Guide for NHS EED.
    38. (2004). Specifying technical change: a research on the nature of technical change in Dutch hospital industry. Q Rev Econ Finance. doi
    39. (2009). Technological Adoption in Health Care. CEPR Discussion Papers 7558; doi
    40. Technological development and medical productivity: the diffusion of angioplasty in New York state. doi
    41. Technology as a major driver of health care costs: a cointegration analysis of the Newhouse conjecture. doi
    42. (1996). The determinants of technological change in heart attack treatment. NBER Working Paper No 5751; doi
    43. The Factors Fueling Risking Healthcare Costs. Report prepared for the American Association of Health Plans;
    44. (1991). The health care quadrilemma: an essay on technological change, insurance, quality of care and cost containment.
    45. (2000). The Impact of Technological Change on Health Care Cost Increases: An Evaluation of the Literature. Health Care Financing Administration Working Paper;
    46. The lifetime costs and benefits of medical technology. doi
    47. The macro determinants of health expenditure in the United States and Canada: assessing the impact of income, age distribution and time. Health Policy. doi
    48. (2010). The Role of Technology on Health Care Expenditure on the EU.
    49. The socio-economic value of orthopaedic devices: Evidence and methodological challenges. Orthopedic Research and Reviews. doi
    50. (1960). The value of medical spending in the United States, doi
    51. (1993). Trends in Medicare payments in the last year of life. doi
    52. Use of cost-effectiveness analysis to evaluate new technologies in orthopaedics: the case of alternative bearing surfaces in total hip arthroplasty.
    53. Value-based purchasing of medical devices. Clin Orthop Relat Res. doi
    54. (2002). Why have Health Expenditures as a Share of GDP Risen So Much? National Bureau of Economic Research Working Paper Series, No 9325; doi

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.